CompletedNot Applicable

Natriuretic Peptides After Left Atrial Appendage Amputation

Germany21 participantsStarted 2015-05-01

Plain-language summary

Surgical amputation of the left atrial appendage (LAA) is an established intervention during surgical atrial fibrillation (AF) therapy. However, its effects on the endocrine function of the left atrium are unclear. This study aims to quantify the serum levels of natriuretic peptides in patients who undergo concomitant surgical AF ablation with or without LAA amputation.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Indication for concomitant AF therapy during cardiac surgery with cardiopulmonary bypass Exclusion Criteria: * Lack of informed consent

What they're measuring

Serum levels of proANP and BNP until 800days post surgery

Timeframe: 800days

Trial details

NCT IDNCT03816410

SponsorUniversity of Giessen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-10-30

View on ClinicalTrials.gov More Atrial Fibrillation trials